"Health & Medical News"

An anti-psychotic drug already approved in the U.S. to treat adults and adolescents with schizophrenia may soon be available for youngsters age 10 to 17 years of age suffering from bipolar disorder.

The U.S. Food and Drug Administration (FDA) has given priority review status to the drug Abilify which is manufactured by Bristol-Myers Squibb and Otsuka Pharmaceutical.

Read the rest of this entry »

Popularity: unranked [?]

Wired magazine has a fascinating piece from last month on the “ultimate medical diagnostic device” which is being developed in collaboration with the private sector. It is by Thomas Goetz who runs his own blog: Epidemix. Excerpts below:

“Our inability to diagnose and track infectious disease quickly and accurately remains a serious problem…The problem with cultures is that they take a long time ??” three weeks or more ??” to produce a definitive result. In those three weeks, antibiotics may be fortifying the bacteria’s resistance rather than curing the patient. In those three weeks, a TB patient goes back into the population and spreads disease. In those three weeks, the bacteria have enough time to escape our grasp. What’s needed, then, is a new way to diagnose the disease: one at least as fast as the sputum microscopy test, as accurate as the culture, and refined enough to differentiate between garden-variety bacteria and drug-resistant strains. What’s needed is nothing less than a new gold standard…Those tests might finally be at hand. There is a crop of diagnostic tools on the horizon… Dozens of companies are investing hundreds of millions of dollars to develop these new tools.”

Read the rest of this entry »

Popularity: 2% [?]